Randal D. Chase is Director at BIOJECT MEDICAL TECHNOLOGIES INC (BJCT). They have made 7 open-market trades across 2 companies since 2006, most recently 2022-09-21.
CIK 0001078784
7 open-market purchases totalling $147K since 2006, never a sale. Across 5 scored buys the stock is down 22.5% at ninety days, and 26.1 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 20% |
| Avg Move | -20.3% | -27.4% | -22.5% |
| Alpha | -48.8% | -29.0% | -26.1% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GOVX | BUY | 2022-09-21 | 2022-09-23 | $1.10 | $11K | -5.2% | -29.7% | -51.3% |
| GOVX | BUY | 2022-06-21 | 2022-06-22 | $1.21 | $12K | -43.9% | -54.3% | -22.3% |
| GOVX | BUY | 2020-09-29 | 2020-09-29 | $5.00 | $83K | +0.0% | -9.9% | +4.3% |
| GOVX | BUY | 2015-05-05 | 2015-05-05 | $0.19 | $2K | -26.1% | -21.6% | -21.6% |
| GOVX | BUY | 2015-04-20 | 2015-04-20 | $0.17 | $5K | -26.1% | -21.6% | -21.6% |
| BJCT | BUY | 2007-06-14 | 2007-06-18 | $1.36 | $14K | N/A | N/A | N/A |
| BJCT | BUY | 2006-06-07 | 2006-06-07 | $1.35 | $20K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.